<?xml version="1.0" encoding="UTF-8"?>
<p id="p0145">The anti-HIV drugs and protease inhibitors Lopinavir and Ritonavir were found to be effective in SARS-CoV infections and also these drugs are currently under the clinical trials for testing the efficacy and safety against SARS-CoV-2 [
 <xref rid="bb0560" ref-type="bibr">112</xref>]. Investigators performed an open-label randomized trial at Wuhan hospital, China. They have given the treatment to adult SARS-CoV-2 patients with oral Lopinavir and Ritonavir (400 &amp; 100 mg, respectively) twice daily for 14 days. They found that Lopinavir and Ritonavir combination was significantly effective against SARS-CoV-2 [
 <xref rid="bb0565" ref-type="bibr">113</xref>]. However, further studies are needed to draw a clear conclusion on the usage of combination of Lopinavir and Ritonavir in SARS-CoV-2.
</p>
